共 48 条
[1]
Millner LM(2016)The future of precision medicine in oncology Clin Lab Med 36 557-573
[2]
Strotman LN(2018)A review of guidelines for lung cancer J Thorac Dis 10 S1556-S1563
[3]
Bironzo P(2020)Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update J Clin Oncol 38 1608-1632
[4]
Di Maio M(2013)Rates of guideline adherence among US community oncologists treating NSCLC Am J Manag Care 19 185-192
[5]
Hanna NH(2006)Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 24 626-634
[6]
Schneider BJ(2012)Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer Lung Cancer 75 255-260
[7]
Temin S(2017)EP-1221: adherence to lung cancer guidelines and its impact on survival Radiother Oncol 123 S659-242
[8]
Wang Z(2020)Real-world adherence to guideline-recommended treatment for small cell lung cancer Am J Clin Oncol 43 236-542
[9]
Askamit I(2020)Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR medRxiv 39 531-54
[10]
Tuscher L(2019)Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices Am Soc Clin Oncol Educ Book 4 49-e119